Radiation Dose Management Market Worth $350 Million by 2020

According to a new market research report “Radiation Dose Management Market by Product (Dose Tracking, Monitoring, and Analytics Software, Consulting Services), by Application (Computed Tomography, Angiography, Fluoroscopy), by End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2020”, the Global Radiation Dose Management Market is expected to reach $350 million by 2020.

Logo

Dallas, TX -- (SBWire) -- 04/22/2015 --Browse 115 market data tables and 37 figures spread through 200 pages and in-depth TOC on "Radiation Dose Management Market"

http://www.marketsandmarkets.com/Market-Reports/radiation-dose-management-market-82326344.html

Early buyers will receive 10% customization on this report.

The radiation dose management market is expected to grow at a high rate in the next four years. This is primarily attributed to the need for radiation dose optimization while performing diagnostic imaging procedures owing to the increasing radiation exposure risks. Moreover, the rising need to comply with regulations which mandate dose monitoring, tracking, and maintenance of patient dose records; legislative and accreditation requirements to avoid penalties; and the need to increase patient safety and improve the quality of healthcare. Government initiatives and funding to bring e-Health to the healthcare sector across the globe has driven the adoption of EMR systems and other healthcare IT systems.

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=82326344

All these systems also require the deployment of radiation dose management to complete the patient medical records and to streamline the workflow. Moreover, factors such as the need to reduce radiation dose levels in interventional imaging and nuclear medicine techniques (as these techniques use high dose levels) and to reduce medical errors owing to manual entry are expected to drive this market in the coming years. Other factors which are propelling the growth of this market include increasing number of multispecialty hospitals, need for quality improvement in healthcare, and improved dose optimization through computerized patient dose information and standardized protocols. However, lack of funding in many regions across the world and lack of standardized protocols in this market owing to its nascent stage are posing a great challenge for this market.

In this report, the market is segmented by product, application, end user, and region. The report also discusses the key market drivers and restraints and the opportunities and trends in this market and its submarkets. The market is expected to grow at a very high CAGR from 2015 to 2020.

You can speak To Research Analyst to know more about Report:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=82326344

In 2014, North America was the major market for radiation dose management, followed by Europe and Asia-Pacific. An alarming increase in patient radiation exposure, highly developed healthcare IT infrastructure, a number of healthcare reforms, advent of new technologies, and favorable regulatory compliance in the North American and European region has led to the major contribution of these regions to the global radiation dose management market.

Prominent players in the radiation dose management market are Bayer AG (Germany), GE Healthcare (U.K.), PACSHealth LLC (U.S.), Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.), McKesson Corporation (U.S.), Siemens Healthcare (Germany), AGFA Healthcare (Belgium), Sectra Medical Systems (Sweden), Toshiba Medical Systems Corporation (Japan), and McKesson Corporation (U.S.).

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain
http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Media Relations Contact

Mr. Rohan
888-600-6441
http://www.marketsandmarkets.com/

View this press release online at: http://rwire.com/593288